Zai Lab Limited
ZLAB
$35.35
$0.661.90%
Weiss Ratings | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.75 | |||
Price History | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 2.05% | |||
30-Day Total Return | 31.71% | |||
60-Day Total Return | 27.48% | |||
90-Day Total Return | 8.64% | |||
Year to Date Total Return | 42.48% | |||
1-Year Total Return | 76.66% | |||
2-Year Total Return | 11.51% | |||
3-Year Total Return | 18.70% | |||
5-Year Total Return | -29.48% | |||
52-Week High % Change | -8.69% | |||
52-Week Low % Change | 157.34% | |||
Price | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $37.99 | |||
52-Week Low Price | $13.48 | |||
52-Week Low Price (Date) | Apr 18, 2024 | |||
52-Week High Price (Date) | Mar 07, 2025 | |||
Valuation | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 3.73B | |||
Enterprise Value | 3.11B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -25.92 | |||
Earnings Per Share Growth | -25.11% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.89 | |||
Price/Book (Q) | 0.44 | |||
Enterprise Value/Revenue (TTM) | 7.78 | |||
Price | $35.35 | |||
Enterprise Value/EBITDA (TTM) | -11.49 | |||
Enterprise Value/EBIT | -11.01 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 10.27M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 86 21 6163 2588 | |||
Address | -- | |||
Website | www.zailaboratory.com | |||
Country | China | |||
Year Founded | 2013 | |||
Profitability | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -70.70% | |||
Profit Margin | -64.43% | |||
Management Effectiveness | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -15.87% | |||
Return on Equity | -- | |||
Income Statement | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 398.99M | |||
Total Revenue (TTM) | 398.99M | |||
Revenue Per Share | $38.86 | |||
Gross Profit (TTM) | 117.73M | |||
EBITDA (TTM) | -270.26M | |||
EBIT (TTM) | -282.12M | |||
Net Income (TTM) | -257.10M | |||
Net Income Avl. to Common (TTM) | -257.10M | |||
Total Revenue Growth (Q YOY) | 65.68% | |||
Earnings Growth (Q YOY) | 14.40% | |||
EPS Diluted (TTM) | -25.92 | |||
EPS Diluted Growth (Q YOY) | 19.11% | |||
Balance Sheet | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 779.67M | |||
Cash Per Share (Q) | $75.93 | |||
Total Current Assets (Q) | 1.05B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 840.90M | |||
Current Ratio (Q) | 3.509 | |||
Book Value Per Share (Q) | $78.03 | |||
Total Assets (Q) | 1.19B | |||
Total Current Liabilities (Q) | 299.39M | |||
Total Debt (Q) | 153.47M | |||
Total Liabilities (Q) | 344.86M | |||
Total Common Equity (Q) | 840.90M | |||
Cash Flow | ZLAB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -375.19M | |||
Cash from Financing (TTM) | 349.89M | |||
Net Change in Cash (TTM) | -240.48M | |||
Levered Free Cash Flow (TTM) | -530.44M | |||
Cash from Operations (TTM) | -214.87M | |||